Your browser is no longer supported. Please, upgrade your browser.
Settings
SCLN SciClone Pharmaceuticals, Inc. daily Stock Chart
SCLN [NASD]
SciClone Pharmaceuticals, Inc.
Index- P/E13.75 EPS (ttm)0.75 Insider Own0.40% Shs Outstand51.30M Perf Week0.49%
Market Cap528.39M Forward P/E- EPS next Y- Insider Trans-84.29% Shs Float45.97M Perf Month19.08%
Income36.90M PEG0.98 EPS next Q- Inst Own76.80% Short Float4.47% Perf Quarter0.68%
Sales158.90M P/S3.33 EPS this Y18.00% Inst Trans-2.83% Short Ratio5.62 Perf Half Y-24.76%
Book/sh4.14 P/B2.49 EPS next Y- ROA16.90% Target Price10.00 Perf Year9.57%
Cash/sh- P/C- EPS next 5Y14.10% ROE19.10% 52W Range7.37 - 15.03 Perf YTD11.96%
Dividend- P/FCF16.36 EPS past 5Y5.80% ROI22.20% 52W High-31.30% Beta1.68
Dividend %- Quick Ratio6.90 Sales past 5Y13.10% Gross Margin85.90% 52W Low40.09% ATR0.42
Employees590 Current Ratio7.50 Sales Q/Q-5.60% Oper. Margin24.20% RSI (14)57.36 Volatility3.82% 4.31%
OptionableYes Debt/Eq0.00 EPS Q/Q2.00% Profit Margin23.20% Rel Volume0.50 Prev Close10.30
ShortableYes LT Debt/Eq0.00 EarningsNov 09 AMC Payout0.00% Avg Volume365.90K Price10.32
Recom4.00 SMA202.66% SMA504.20% SMA200-7.88% Volume91,023 Change0.24%
Nov-29-16Initiated Maxim Group Buy $14
Nov-14-14Downgrade BWS Financial Buy → Hold $8.25 → $8
Nov-12-13Reiterated Aegis Capital Buy $9 → $8
Jul-16-13Upgrade Aegis Capital Hold → Buy $9
Sep-18-12Upgrade BWS Financial Hold → Buy $8.25
Aug-10-10Downgrade BWS Financial Buy → Hold $7.25 → $4.50
Apr-09-10Upgrade BWS Financial Hold → Buy $7.25
Jul-08-09Downgrade BWS Financial Buy → Hold $3.25
Jun-03-09Initiated ThinkEquity Buy $5
May-21-09Initiated Rodman & Renshaw Mkt Outperform $5
Sep-05-08Initiated Susquehanna Financial Neutral
Dec-02-16 09:39AM  Do Hedge Funds Love Rent-A-Center Inc (RCII)? at Insider Monkey
Nov-29-16 05:43AM  Coverage initiated on SciClone Pharma by Maxim Group
Nov-28-16 01:19PM  Is Retrophin Inc (RTRX) A Good Stock To Buy? at Insider Monkey
Nov-17-16 01:04PM  SCICLONE PHARMACEUTICALS INC Financials
Nov-16-16 12:13PM  ETFs with exposure to SciClone Pharmaceuticals, Inc. : November 16, 2016
Nov-15-16 07:34AM  SciClone Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : SCLN-US : November 15, 2016
Nov-14-16 04:05PM  SciClone Confirms Receipt Of Unsolicited Proposal From GL Capital And ABG Management PR Newswire +5.08%
08:24AM  Early movers: HAR, MENT, PFE, NVS, TM, JNJ, HPE, DUK, KO, CHS & more at CNBC
Nov-09-16 11:47PM  Edited Transcript of SCLN earnings conference call or presentation 9-Nov-16 9:30pm GMT +8.74%
05:12PM  SciClone posts 3Q profit
04:12PM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
04:05PM  SciClone Reports Third Quarter 2016 Financial Results PR Newswire
07:07AM  Q3 2016 SciClone Pharmaceuticals Inc Earnings Release - After Market Close
Nov-01-16 12:18PM  ETFs with exposure to SciClone Pharmaceuticals, Inc. : November 1, 2016
Oct-25-16 12:24PM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Other Events
06:00AM  SciClone Pharmaceuticals To Report Third Quarter 2016 Financial Results On November 9, 2016 PR Newswire
Oct-11-16 08:16AM  SciClone Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : SCLN-US : October 11, 2016
Sep-29-16 10:16AM  SciClone Pharmaceuticals, Inc. Value Analysis (NASDAQ:SCLN) : September 29, 2016
Sep-28-16 08:16AM  SciClone Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : SCLN-US : September 28, 2016
Sep-26-16 06:00AM  SciClone Announces Progress In Advancing Clinical Pipeline For China Pharmaceuticals Market PR Newswire
Sep-12-16 11:15AM  Soligenix (SNGX) and SciClone (SCLN) Establish Regional Licensing Agreement for SGX942, a Novel Product Candidate for Oral Mucositis
07:00AM  Soligenix and SciClone Establish Regional Licensing Agreement for SGX942, a Novel Product Candidate for Oral Mucositis PR Newswire
Sep-01-16 04:05PM  SciClone To Present At Two Investor Conferences In September 2016 PR Newswire
Aug-31-16 11:49AM  ETFs with exposure to SciClone Pharmaceuticals, Inc. : August 31, 2016
Aug-18-16 11:15PM  Sciclone Pharmaceuticals Inc (SCLN) President & CEO Friedhelm Blobel Sold $5 million of Stocks
Aug-16-16 12:40PM  ETFs with exposure to SciClone Pharmaceuticals, Inc. : August 16, 2016
Aug-15-16 01:20PM  SciClone Pharmaceuticals, Inc. :SCLN-US: Earnings Analysis: Q2, 2016 By the Numbers : August 15, 2016
Aug-10-16 12:41PM  Are High Composite Ratings An Automatic 'Buy' Signal? No. Here's Why
Aug-09-16 05:59PM  SciClone posts 2Q profit
04:08PM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
04:05PM  SciClone Reports Second Quarter 2016 Financial Results PR Newswire
07:07AM  Q2 2016 SciClone Pharmaceuticals Inc Earnings Release - Time Not Supplied
Aug-03-16 02:02PM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Financial Statements and Exhibits
Jul-28-16 06:00AM  SciClone Pharmaceuticals To Report Second Quarter 2016 Financial Results On August 9, 2016 PR Newswire
Jul-20-16 12:52PM  ETFs with exposure to SciClone Pharmaceuticals, Inc. : July 20, 2016
Jul-19-16 11:37AM  Whats the Deal With These Five Stocks Trading in Red on Tuesday? at Insider Monkey -20.81%
09:21AM  SciClone Pharmaceuticals' stock tumbles after ending discussions with acquirers at MarketWatch
06:00AM  SciClone Provides Update On Strategic Review Process PR Newswire
Jul-11-16 09:58AM  SciClone Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : SCLN-US : July 11, 2016
Jul-06-16 02:39PM  ETFs with exposure to SciClone Pharmaceuticals, Inc. : July 6, 2016
Jun-27-16 04:29PM  SciClone Pharmaceuticals, Inc. Value Analysis (NASDAQ:SCLN) : June 27, 2016
Jun-24-16 09:01AM  SciClone Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : SCLN-US : June 24, 2016
Jun-15-16 12:36PM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to
Jun-03-16 03:40PM  ETFs with exposure to SciClone Pharmaceuticals, Inc. : June 3, 2016
03:19PM  3 Biotech Stocks Headed for New Highs (SCLN, SUPN) at Investopedia
May-24-16 03:36PM  ETFs with exposure to SciClone Pharmaceuticals, Inc. : May 24, 2016
May-23-16 02:04PM  SciClone Pharmaceuticals, Inc. :SCLN-US: Earnings Analysis: Q1, 2016 By the Numbers : May 23, 2016
May-10-16 02:29PM  Edited Transcript of SCLN earnings conference call or presentation 10-May-16 12:30pm GMT -5.42%
07:34AM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
07:07AM  Q1 2016 SciClone Pharmaceuticals Inc Earnings Release - After Market Close
06:14AM  SciClone posts 1Q profit
06:00AM  SciClone Reports First Quarter 2016 Financial Results PR Newswire
May-03-16 09:05AM  3 Underfollowed Infectious Disease Stocks That Deserve More Attention at 24/7 Wall St.
Apr-25-16 06:00AM  SciClone Pharmaceuticals To Report First Quarter 2016 Financial Results On May 10, 2016 PR Newswire
Apr-16-16 09:00AM  'Mad Money' Lightning Round: Con Ed, Regeneron Are My Picks at TheStreet
Apr-01-16 04:23PM  SciClone Pharmaceuticals, Inc.: Leads amongst peers with strong fundamentals
Mar-31-16 03:50PM  Here's Why SciClone Pharmaceuticals' Shares Are Soaring 14% Today at Motley Fool +13.75%
07:21AM  SunEdison's Market Cap 'Is No Longer Representative Of The Mid-Cap Market Space'
Mar-30-16 06:24PM  WebMD Health Set to Join the S&P MidCap 400; SciClone Pharmaceuticals to Join S&P SmallCap 600 PR Newswire
06:00AM  SciClone To Present At Needham Healthcare Conference On April 13, 2016 PR Newswire
Mar-24-16 05:50PM  ETFs with exposure to SciClone Pharmaceuticals, Inc. : March 24, 2016
05:41PM  Soligenix Announces Recent Accomplishments and Year-End 2015 Financial Results at noodls
Mar-21-16 02:32PM  SciClone Pharmaceuticals, Inc. :SCLN-US: Earnings Analysis: Q4, 2015 By the Numbers
11:56AM  SciClone Pharmaceuticals, Inc. :SCLN-US: Earnings Analysis: 2015 By the Numbers
09:00AM  OxySure Therapeutics (OXYS) May Be Undervalued Compared to Others in Biotech Space Accesswire
Mar-11-16 01:29PM  SCICLONE PHARMACEUTICALS INC Files SEC form 10-K, Annual Report
05:01AM  SciClone posts 4Q profit
Mar-10-16 11:11PM  Edited Transcript of SCLN earnings conference call or presentation 10-Mar-16 9:30pm GMT
04:12PM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
04:05PM  SciClone Reports 2015 Financial Results PR Newswire
07:07AM  Q4 2015 SciClone Pharmaceuticals Inc Earnings Release - After Market Close
Mar-08-16 02:45PM  LifeSci Capital Initiates Coverage of SciClone Accesswire
Feb-22-16 06:00AM  SciClone Pharmaceuticals To Report 2015 Financial Results On March 10, 2016 PR Newswire
Feb-08-16 08:05AM  SciClone Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : February 8, 2016
Feb-04-16 06:29PM  [$$] SciClone Launches Strategic Review at The Wall Street Journal
05:09PM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
05:01PM  SciClone Announces Final Resolution With The Securities And Exchange Commission And The Department Of Justice PR Newswire
Jan-27-16 06:00AM  SciClone To Present At BIO CEO & Investor Conference On February 9, 2016 PR Newswire
Jan-26-16 04:32PM  Soligenix Provides 2016 Business Outlook Reviews 2015 Achievements and 2016 Milestones at noodls
Jan-11-16 09:02AM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
06:00AM  SciClone Announces Preliminary 2015 Revenue PR Newswire
Jan-05-16 08:46AM  SciClone Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : January 5, 2016
Dec-21-15 12:51PM  SciClone Pharmaceuticals, Inc. Earnings Analysis: Q3, 2015 By the Numbers
06:00AM  SciClone To Pursue Development Of SGX942 In China Following Soligenix' Report Of Positive Phase 2 Preliminary Results In Oral Mucositis PR Newswire
Dec-18-15 08:00AM  Healthcare Sector Equities under the Scanner -- Zogenix, Amarin, SciClone Pharma, and PetMed Express Accesswire
Nov-27-15 09:17AM  Hedge Funds Arent Crazy About SciClone Pharmaceuticals, Inc. (SCLN) Anymore at Insider Monkey
Nov-24-15 04:18PM  Is Tristate Capital Holdings Inc (TSC) A Good Stock To Buy? at Insider Monkey
Nov-20-15 07:45AM  What's Moving the Markets - Research on Aegean Marine, REX American Resources, SciClone and Blue Nile Accesswire
Nov-17-15 11:57AM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement
06:00AM  SciClone To Present At 27th Annual Piper Jaffray Healthcare Conference On December 2, 2015 PR Newswire
Nov-14-15 09:20AM  7 BioHealth Movers That Cannot Be Ignored at 24/7 Wall St.
Nov-12-15 08:05AM  Moving Ahead of Averages, Technical Review - Research on Aegean Marine Petroleum Network, SciClone Pharmaceuticals, Noodles & Co, and Nuveen Floating Rate Income Opportunity Fund Accesswire -11.60%
Nov-11-15 04:26PM  SciClone Pharmaceuticals, Inc.: Leads amongst peers with strong fundamentals
01:00PM  Theravance Biopharma Posts Wider-than-Expected Q3 Loss
12:17PM  Story Stocks from Briefing.com Briefing.com
Nov-10-15 03:18PM  4 Stocks That Moved Massively After Earnings at 24/7 Wall St. +20.90%
02:16PM  Why SciClone Pharmaceuticals Is Soaring Today at Motley Fool
11:59AM  Here Is Why These Four Stocks Stand Out from the Crowd on Tuesday at Insider Monkey
03:53AM  Edited Transcript of SCLN earnings conference call or presentation 9-Nov-15 9:30pm GMT
01:16AM  Trending Now: SCLN
SciClone Pharmaceuticals, Inc., a specialty pharmaceutical company, provides therapies for oncology, infectious diseases, and cardiovascular disorders in the People's Republic of China, the United States, and Hong Kong. Its lead product is ZADAXIN, which is used for the treatment of hepatitis B and hepatitis C viruses, and certain cancers, as well as for use as an immune system enhancer. In addition, the company focuses on developing ZADAXIN for the treatment of sepsis. SciClone Pharmaceuticals, Inc. markets and sells ZADAXIN through distribution arrangements, local importers, and distributors. It markets and distributes products, such as DC Bead, Holoxan, Mesna, Endoxan, Methotrexate, Estracyt, Farlutal, Neucardin, ProFlow, Angiomax, and Cleviprex. The company has an agreement with MEDA Pharma GmbH & Co. KG for the development of Tramadol. SciClone Pharmaceuticals, Inc. was founded in 1989 and is headquartered in Foster City, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Blobel FriedhelmPresident & CEONov 22Option Exercise1.8114,14725,606100,931Nov 23 04:06 PM
Blobel FriedhelmPresident & CEONov 22Sale10.2014,147144,26586,784Nov 23 04:06 PM
Blobel FriedhelmPresident & CEONov 21Option Exercise1.8155,853101,094126,784Nov 23 04:06 PM
Blobel FriedhelmPresident & CEONov 21Sale10.2255,853570,91386,784Nov 23 04:06 PM
Blobel FriedhelmPresident & CEONov 14Option Exercise1.8124,69944,705111,483Nov 15 04:17 PM
Blobel FriedhelmPresident & CEONov 14Sale10.3324,699255,08686,784Nov 15 04:17 PM
Blobel FriedhelmPresident & CEONov 11Option Exercise1.815,3019,59592,085Nov 15 04:17 PM
Blobel FriedhelmPresident & CEONov 11Sale10.015,30153,05186,784Nov 15 04:17 PM
Blobel FriedhelmPresident & CEOOct 27Option Exercise1.8140,00072,400126,784Oct 28 04:22 PM
Blobel FriedhelmPresident & CEOOct 27Sale9.3040,000371,89286,784Oct 28 04:22 PM
Cheung Wilson Wai-ShunCFO & Senior VP, FinanceOct 26Option Exercise5.48134,828739,37248,995Oct 27 01:00 PM
Cheung Wilson Wai-ShunCFO & Senior VP, FinanceOct 26Sale10.00149,8921,498,9200Oct 27 01:00 PM
Cheung Wilson Wai-ShunCFO & Senior VP, FinanceOct 25Sale10.007070015,064Oct 27 01:00 PM
Cheung Wilson Wai-ShunCFO & Senior VP, FinanceOct 17Option Exercise5.971,0056,00016,609Oct 19 04:49 PM
Cheung Wilson Wai-ShunCFO & Senior VP, FinanceOct 17Sale10.001,47514,75015,134Oct 19 04:49 PM
CHANG NANCY TDirectorSep 29Option Exercise5.2040,981213,00370,000Sep 29 08:20 PM
CHANG NANCY TDirectorAug 30Sale10.337,54077,8870Aug 30 04:41 PM
Cheung Wilson Wai-ShunCFO & Senior VP, FinanceAug 29Sale10.351,87219,37015,604Aug 29 05:12 PM
CHANG NANCY TDirectorAug 29Sale10.3110,000103,1197,540Aug 30 04:41 PM
CHANG NANCY TDirectorAug 26Sale10.257,50076,89117,540Aug 30 04:41 PM
Blobel FriedhelmPresident & CEOAug 17Option Exercise1.08100,000108,000588,255Aug 18 07:19 PM
Blobel FriedhelmPresident & CEOAug 17Sale10.00501,8755,018,75086,380Aug 18 07:19 PM
Cheung Wilson Wai-ShunCFO & Senior VP, FinanceAug 16Sale10.627,80282,83717,476Aug 16 02:43 PM
Cheung Wilson Wai-ShunCFO & Senior VP, FinanceAug 12Option Exercise0.0040,500040,500Aug 16 02:43 PM
Blobel FriedhelmPresident & CEOAug 12Option Exercise0.0058,5000518,782Aug 16 05:41 PM
Xie LanVP Finance, China CFOAug 12Option Exercise5.8632,832192,29912,187Aug 16 05:36 PM
Low Raymond AnthonyVP, Finance & ControllerAug 12Option Exercise0.001,250010,908Aug 16 05:34 PM
Zhao HongCEO, China OperationsAug 12Option Exercise0.0040,500025,000Aug 16 05:39 PM
Hawkins Richard JDirectorAug 12Option Exercise2.40120,000288,00054,363Aug 16 05:21 PM
King RobertSVP of Prod. Dev/Supply ChainAug 12Option Exercise4.3348,667210,93563,511Aug 16 05:28 PM
Meng ChuncaiGen. Counsel & VP ComplianceAug 12Option Exercise5.3831,083167,27523,333Aug 16 05:32 PM
King RobertSVP of Prod. Dev/Supply ChainAug 12Sale10.4148,667506,62316,844Aug 16 05:28 PM
Hawkins Richard JDirectorAug 12Sale10.37120,0001,244,72424,363Aug 16 05:21 PM
Xie LanVP Finance, China CFOAug 12Sale10.3632,832340,2210Aug 16 05:36 PM
Meng ChuncaiGen. Counsel & VP ComplianceAug 12Sale10.4131,083323,5740Aug 16 05:32 PM
Zhao HongCEO, China OperationsAug 12Sale10.4140,500421,6050Aug 16 05:39 PM
Hawkins Richard JDirectorMay 05Option Exercise2.4630,00073,80030,000May 09 11:04 AM
Blobel FriedhelmPresident & CEOApr 11Option Exercise2.49659,8001,642,902765,792Apr 13 10:55 AM
Blobel FriedhelmPresident & CEOMar 28Option Exercise2.4910,00024,900214,412Mar 30 11:20 AM
Blobel FriedhelmPresident & CEOMar 28Sale9.2910,00092,878205,252Mar 30 11:20 AM
Blobel FriedhelmPresident & CEOMar 18Option Exercise2.4910,00024,900215,252Mar 21 02:29 PM
Blobel FriedhelmPresident & CEOMar 18Sale9.0910,00090,936205,252Mar 21 02:29 PM
Blobel FriedhelmPresident & CEOFeb 26Option Exercise2.4910,00024,900214,252Mar 01 03:41 PM
Blobel FriedhelmPresident & CEOFeb 26Sale9.9810,00099,771204,252Mar 01 03:41 PM
Blobel FriedhelmPresident & CEOJan 04Option Exercise2.49200498204,452Jan 06 01:33 PM
SAXE JON SDirectorJan 04Option Exercise2.4630,00073,800105,000Jan 06 01:40 PM
Blobel FriedhelmPresident & CEOJan 04Sale9.012001,802204,252Jan 06 01:33 PM
Blobel FriedhelmPresident & CEODec 28Option Exercise2.4910,00024,900214,252Dec 29 12:19 PM
Blobel FriedhelmPresident & CEODec 28Sale9.1710,00091,697204,252Dec 29 12:19 PM
Blobel FriedhelmPresident & CEODec 17Option Exercise2.499,40023,406211,673Dec 18 05:40 PM
Blobel FriedhelmPresident & CEODec 17Sale9.009,40084,600202,273Dec 18 05:40 PM
Blobel FriedhelmPresident & CEODec 11Option Exercise2.496001,494202,873Dec 14 05:39 PM
Blobel FriedhelmPresident & CEODec 11Sale9.006005,402202,273Dec 14 05:39 PM